Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure

Circulation

Volumn 93, Issue 4, 1996, Pages 646-651

  Cannan, Charles R ^a   Burnett Jr , John C ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

arteries; endothelin; heart failure; receptors; vasoconstriction

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR; SARAFOTOXIN;

ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY VASCULAR RESISTANCE; DOG; INTRAARTERIAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030053456     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.4.646     Document Type: Article

References (26)

1. Bristow MR, Ginsburg R, Minobe W, Cubociotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson E. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
2. Margulies KB, Hildebrand FL Jr, Lerman A, Perella MA, Burnett JC Jr. Increased endothelin in experimental heart failure. Circulation. 1990;82;2226-2230.
3. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and following cardiac transplantation. J Am Coll Cardiol. 1992;20: 849-853.
4. Clavell AL, Stingo AJ, Margulies KB, Brandt RR, Burnett JC Jr. Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol. 1995;268:F455-F460.
5. Teerlink JR, Löffler BM, Hess P, Maire JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Circulation. 1994;90: 2510-2518.
6. Lerman A, Burnett JC Jr. Intact and altered endothelium in regulation of vasomotion. Circulation. 1992;86(suppl III):III-12-111-19.
7. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, St John Sutton MG, Selwyn AP, Alexander RW, Ganz P. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990;81: 772-779.
8. Miller WL, Redfield MM, Burnett JC Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest. 1989;83:317-320.
9. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr. Endothelin has biological actions at pathophysiological concentration. Circulation. 1991;83:1808-1814.
10. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation: implications for vascular function. Circulation. 1991;84:1457-1468.
11. Goto K, Kasuya Y, Matsuki N, Takuwa Y, Kurihara H, Ishikawa T, Kimura S, Yanagisawa M, Masaki T. Endothelin activates the dihydropyridine-sensitive, voltage-dependent calcium channel in vascular smooth muscle. Proc Natl Acad Sci U S A. 1989;86: 3915-3918.
12. Kasua Y, Takuwa Y, Yanagisawa M, Kimura S, Goto K, Masaki T. Endothelin-1 induces vasoconstriction through two functionally distinct pathways in the porcine coronary artery: contribution of phosphoinositide turnover. Biochem Biophys Res Commun. 1989; 161:1049-1055.
13. Lüscher TF, Oemar BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors, part I. J Hypertens. 1993;11:7-11,121-126.
14. Rigel DF, Lappe RW. Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J Cardiovasc Pharmacol. 1993;(suppl 8):S243-S247.
15. Cannan CR, Brandt RR, Burnett JC Jr, Lerman A. Endothelin-1 at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation. 1995;92: 3312-3317.
16. Löffler B-M, Roux S, Kalina B, Clozel M, Clozel J-P. Influence of congestive heart failure on endothelin levels and receptors in rabbits. J Mol Cell Cardiol. 1993;25:407-416.
17. Calderone A, Rouleau JL, de Champlain J, Bélichard P, Stewart DJ. Regulation of the endothelin-1 transmembrane signalling pathway: the potential role of agonist-induced desensitization in the coronary artery of the rapid ventricular pacing-overdrive dog model of heart failure. J Mol Cell Cardiol. 1993;25:895-903.
18. Underwood D, Aarhus L, Heublein D, Burnett JC Jr. Endothelin in thoracic inferior vena caval constriction. Am J Physiol. 1992;263: H951-H955.
19. Chu A, Murray JJ, Lin C-C, Russell M, Hagen PO, Cobb FR. Preferential proximal coronary dilation by activators of guanylate cyclase in awake dogs. Am J Physiol. 1990;259:H340-H345.
20. Williams DL Jr, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV. Sarafotoxin-S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun. 1991;175: 556-561.
21. Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett JC Jr. Endothelin in experimental heart failure in the anesthetized dog. Am J Physiol. 1990;259:F312-F317.
22. Fu L-X, Sun X, Hedner T, Feng Q-P, Liang Q-M, Hoebeke J, Hjalmarson A. Decreased density of mesenteric arteries but not of myocardial endothelin receptors and function in rats with chronic ischemic heart failure. J Cardiovasc Pharmacol. 1993;22: 177-182.
23. O'Murchu B, Miller VM, Perrella MA, Burnett JC Jr. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest. 1994;93:165-171.
24. Lerman A, Sandok EK, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr. Inhibition of endothelium-derived relaxing factor enhances the vasoconstrictor response to endothelin. Circulation. 1992;85: 1894-1989.
25. Kiowski W, Sütsch G, Hunziker P, Müller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346: 732-736.
26. Yanagisawa M. The endothelin system: a target for therapeutic intervention. Circulation. 1994;89:1320-1322.